61 results
Page 3 of 4
8-K
EX-10.1
bi6du74pdgbs 08m9
25 Jun 20
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
p18oct chh1zqiar
18 Jun 20
Corporate Presentation J u n e 2 0 2 0 SELB
8:50am
8-K
EX-99.1
mmxm438mzens1ks
13 Jan 20
Corporate Presentation January 2020 SELB
8:15am
8-K
EX-99.1
d3ggk93zf18
30 Sep 19
Corporate Presentation October 2019 SELB
4:48pm
S-8
EX-99.1
qaqjy19 qdbg7m0bs811
26 Mar 19
Registration of securities for employees
9:28am
8-K
EX-10.1
aov2tzuf9buuf3uc
8 Mar 19
Departure of Directors or Certain Officers
4:32pm
8-K
EX-99.1
q9nhdjmh 3vdi2
7 Jan 19
Regulation FD Disclosure
8:00am
8-K
EX-10.1
gsur5q0ur 4x64k
3 Dec 18
Departure of Directors or Certain Officers
8:06am
S-8
EX-99.1
rb2rkwkwzm
8 Nov 18
Registration of securities for employees
8:16am
8-K
EX-10.1
4bir7lj9rbegi
15 Jun 18
Selecta Biosciences Presents Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at EULAR 2018
12:00am
10-K
xm5s6zol
28 Mar 17
Annual report
12:00am